STAT Plus: Teladoc’s tussle with Amwell raises questions about defining property rights in digital health
The field of health tech is facing a big question: Can it establish strong patent protections akin to those enjoyed by drug companies — or will it become more like the broader technology industry, where patent claims are generally harder to enforce?
The latest skirmish involves accusations by Teladoc that rival Amwell is infringing on patents tied to several digital devices. If it boils into another lawsuit, the case will be closely watched as a potential precedent following an earlier fight between the companies.
